EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
-14.41%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(-17%)
Cap. Flow
-$2.57M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
51.19%
Holding
54
New
8
Increased
17
Reduced
15
Closed
8
Top Buys
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$2.71M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$2.58M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$2.56M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$2.23M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.98M |
Top Sells
| 1 |
DBVT
DBV Technologies
DBVT
|
$3.11M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.96M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$2.64M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.58M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$2.54M |
Sector Composition
| 1 | Healthcare | 48.32% |
| 2 | Financials | 34.37% |
| 3 | Consumer Discretionary | 6.74% |
| 4 | Industrials | 2.63% |
| 5 | Real Estate | 1.37% |